News Quantified

Stock Stats

News Stats


All News	{{AllNewsCount}}
News Wires	{{NewsWiresCount}}
Media Monitoring	{{MoreOverCount}}
SEC Edgar Filings	{{SecEdgarFilingsCount}}
Upgrades	{{UpgradesCount}}
Downgrades	{{DowngradesCount}}
Initiated	{{InitiatesCount}}
Reiterated	{{ReiteratesCount}}
Last Earnings	{{LastEarnings}}
Last Earnings EPS	{{LastEps}}
Next Earnings	{{NextEarnings}}

Order Stats

Sub-Penny
{{SubPennyStr}}
Odd Lot
{{OddLotStr}}
Avg. bid-ask spread

{{GetAvgBidAskSpreadForScale}}
Avg. bid / ask size
{{GetAvgBidSizeForScale}} {{GetAvgAskSizeForScale}}

Shares at ask / bid
{{SharesAtAsk_AMP_Str}} {{SharesAtBid_AMP_Str}}
Off exchange
{{OffExchange}}

News

Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences [Yahoo! Finance]

Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences

Phathom Pharmaceuticals (PHAT) was upgraded by Barclays PLC from "equal weight" to "overweight". They now have a $18.00 price target on the stock, up from $16.00.

Phathom Pharmaceuticals, Inc. (PHAT) Presents at Barclays 28th Annual Global Healthcare Conference Transcript [Seeking Alpha]

Guggenheim Raises PT on Phathom Pharmaceuticals (PHAT) to $25 From $20, Here's Why [Yahoo! Finance]

2/26/2026

07:00 am

PHAT

5.0%

BEAT

10/30/2025

07:00 am

PHAT

-5.2%

BEAT

8/7/2025

06:59 am

PHAT

8.1%

BEAT

5/1/2025

07:00 am

PHAT

-18.0%

BEAT

Form DEFA14A Phathom Pharmaceuticals,

Form ARS Phathom Pharmaceuticals, For: Dec 31

Form DEF 14A Phathom Pharmaceuticals, For: May 19

Form S-8 Phathom Pharmaceuticals,

Form SCHEDULE 13G Phathom Pharmaceuticals, Filed by: MILLENNIUM MANAGEMENT LLC

52 Week High	{{GetCompanyStockInfo.Week52HighValue}} {{GetCompanyStockInfo.Week52HighDate}}
52 Week Low	{{GetCompanyStockInfo.Week52LowValue}} {{GetCompanyStockInfo.Week52LowDate}}

Today’s Volatility	{{VolatilityStr}}
20 Day Volatility	{{Volatility20Str}}

Open	{{GetCompanyStockInfo.Open}}
Prior Close	{{GetCompanyStockInfo.PriorCloseValue}} {{GetCompanyStockInfo.PriorCloseDate}}